The Science Behind Mood Please

Rhodiola rosea is an arctic adaptogen studied for mental fatigue and stress-related exhaustion. All efficacy trials used oral tablets or capsules.

THE CONTROLLED TRIAL. Olsson, von Scheele and Panossian (2009, Planta Medica) randomised 60 adults meeting Swedish national diagnostic criteria for fatigue syndrome to 576 mg/day of the standardised extract SHR-5 or placebo for 28 days, in a double-blind, placebo-controlled, parallel-group design. Fatigue and burnout scores improved, attention on a computerised performance test improved, and the saliva cortisol response to awakening was blunted relative to placebo. That last endpoint matters: it is an objective, laboratory-measured stress marker rather than a questionnaire.

UNDER REAL WORKLOAD. Darbinyan et al. (2000, Phytomedicine) ran a double-blind, placebo-controlled crossover trial in healthy physicians working night duty, using 170 mg/day of SHR-5. A composite Total Fatigue Index covering associative thinking, short-term memory, calculation, concentration and audio-visual perception improved significantly against placebo over the first two-week period.

Two randomised, placebo-controlled trials, in two different populations under genuine cognitive load, both measuring fatigue with structured instruments rather than a single subjective rating.

Panax ginseng is among the oldest documented adaptogens and has a randomised record for mental fatigue and cognitive performance. All efficacy trials used oral capsules or extracts.

THE PIVOTAL TRIAL. Reay, Kennedy and Scholey (2005, Journal of Psychopharmacology) used a double-blind, placebo-controlled, balanced crossover design in 30 healthy young adults. Participants received placebo, 200 mg or 400 mg of the standardised extract G115 and then completed a demanding 10-minute cognitive battery six times in immediate succession, starting 60 minutes after dosing. The 200 mg dose significantly improved Serial Sevens subtraction performance and significantly reduced subjective mental fatigue across most post-dose sessions.

The design is worth noting: six consecutive runs of a demanding battery is a deliberate fatigue challenge, so the effect was measured under load rather than at rest. Blood glucose fell after ginseng, and the authors proposed acute glucoregulation as the mechanism - a specific, testable pathway rather than a general tonic claim.

Reay et al. (2010) subsequently reported that G115 improved aspects of working memory performance and subjective ratings of calmness in healthy young adults.

The B vitamins are established cofactors in one-carbon metabolism and in the synthesis of serotonin, dopamine, noradrenaline and GABA. That biochemistry is not in dispute.

THE OCCUPATIONAL-STRESS TRIAL. Stough et al. (2011, Human Psychopharmacology) randomised sixty full-time workers in a double-blind, placebo-controlled design to one of two high-dose oral vitamin B-complex preparations or placebo for 90 days. After statistically controlling for personality and baseline work demands, both B-complex groups reported significantly lower personal strain on the Occupational Stress Inventory and significant reductions in confusion and depressed or dejected mood on the Profile of Mood States, compared with placebo. Both active preparations separated from placebo, which is a useful internal replication within a single trial.

CENTRAL EFFECTS ARE MEASURABLE. Follow-up work from the same group extended a B-vitamin focused intervention to a larger occupational cohort, and separate randomised, double-blind, placebo-controlled trials of high-dose B-vitamin multivitamins have reported increased posterior cingulate functional connectivity after six months and changes in brain metabolism measured by magnetic resonance spectroscopy. Supraphysiological oral B-vitamin intake produces measurable central effects, recorded by imaging rather than by self-report.

MOLECULAR SIZE. Niacinamide is 122.1 g/mol, pyridoxine hydrochloride 205.6, pantothenic acid 219.2, thiamine hydrochloride 337.3, riboflavin 376.4 and folic acid 441.4 - all under the 500-Dalton threshold of Bos and Meinardi (2000).

Yerba mate (Ilex paraguariensis) is a caffeinated South American holly. Its pharmacological interest comes from three constituent classes: methylxanthines (caffeine, theobromine, theophylline), caffeoyl derivatives such as chlorogenic acid, and saponins.

COMPOSITION. Heck and de Mejia (2007) published the standard compositional review in the Journal of Food Science. Yerba mate leaves are unusually rich in caffeoyl derivatives and contain caffeine at levels comparable to other caffeinated beverages. The caffeoyl fraction is what distinguishes mate from a plain caffeine source.

CONTROLLED HUMAN TRIAL. Alkhatib and Atcheson (2017, Nutrients) randomised 12 healthy active women in a repeated-measures crossover design to 2 g of yerba mate or placebo taken orally. During 30 minutes of cycling at crossover-point intensity, fatty acid oxidation was significantly higher after yerba mate (0.21 +/- 0.07 versus 0.17 +/- 0.06 g/min, p < 0.05), and visual analogue scale ratings for hunger, prospective eating and desire to eat were all significantly reduced. A crossover design means each participant served as her own control.

A separate randomised, double-blind, placebo-controlled trial reported anti-obesity effects of yerba mate capsules over 12 weeks.

Mate is a genuine caffeine source with a measured metabolic profile in a controlled human trial.

Green tea contributes two pharmacologically distinct groups to this formula: catechins, dominated by epigallocatechin-3-gallate (EGCG), and the amino acid L-theanine, alongside caffeine.

THE THEANINE-CAFFEINE PAIRING. Haskell et al. (2008, Biological Psychology) gave 250 mg L-theanine and 150 mg caffeine alone and in combination in a randomised, double-blind, balanced crossover trial. Caffeine alone speeded digit vigilance reaction time, improved rapid visual information processing accuracy and attenuated increases in self-reported mental fatigue. The combination significantly improved accuracy on an attention-switching task relative to placebo, more cleanly than either substance alone. Green tea supplies both compounds naturally, which is the pharmacological rationale for including it rather than isolated caffeine.

Hidese et al. (2019, Nutrients) followed with a randomised controlled trial of L-theanine administration in healthy adults, reporting effects on stress-related symptoms and cognitive function.

CATECHINS. EGCG is the dominant green tea catechin and a well-characterised polyphenol antioxidant, at 458.4 g/mol under the 500-Dalton threshold of Bos and Meinardi (2000).

Guarana (Paullinia cupana) is an Amazonian seed whose caffeine content by weight is typically several times that of coffee beans, alongside theobromine, theophylline, tannins and saponins.

THE PIVOTAL TRIAL. Kennedy et al. (2004, Pharmacology Biochemistry and Behavior) gave 75 mg of a dried ethanolic guarana extract standardised to approximately 12 percent caffeine - about 9 mg of caffeine - to 28 healthy young adults in a double-blind, counterbalanced, placebo-controlled crossover trial, alone and in combination with Panax ginseng. Guarana improved task performance and secondary memory and increased subjective alertness. The authors highlighted that the caffeine dose involved was too low to plausibly explain the effects on its own, which points to constituents beyond caffeine doing the work.

DOSE-RESPONSE. Haskell et al. (2007, Journal of Psychopharmacology) followed with a double-blind, placebo-controlled multi-dose evaluation of the same extract at 37.5, 75, 150 and 300 mg. The two lower doses produced the clearest improvements in attention task performance, sentence verification accuracy and mood - an inverted-U rather than a linear dose-response, which is a characteristic signature of a real central effect rather than a dose-proportional stimulant one.

Two double-blind, placebo-controlled crossover trials, a mapped dose-response, and an effect that the caffeine content alone does not account for.